Fate Therapeutics (FATE) Receivables (2015 - 2026)
Fate Therapeutics (FATE) posted Receivables of $704000.0 for Q1 2026, down 23.14% on a QoQ basis from $916000.0 in Q4 2025, and down 70.74% year-over-year from $2.4 million in Q1 2025.
Fate Therapeutics (FATE) Receivables (2015 - 2026) Analysis & Trends
Fate Therapeutics' Receivables history runs 10 years deep, the most recent figure standing at $704000.0 for Q1 2026.
- Quarterly Receivables fell 70.74% year-over-year to $704000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $704000.0 (down 70.74% YoY) and the FY2025 annual result came in at $916000.0, down 74.12% from the prior year.
- Receivables was $704000.0 for Q1 2026 at Fate Therapeutics, down from $916000.0 in the prior quarter.
- Across five years, Receivables topped out at $38.5 million in Q4 2022 and bottomed at $682000.0 in Q3 2025.
- A 5-year average of $6.5 million and a median of $2.4 million in 2025 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables soared 343.52% — and 2023, when it tumbled 95.25%.
- Fate Therapeutics' Receivables stood at $38.5 million in 2022, then tumbled by 95.25% to $1.8 million in 2023, then jumped by 93.81% to $3.5 million in 2024, then plunged by 74.12% to $916000.0 in 2025, then decreased by 23.14% to $704000.0 in 2026.
- Business Quant data shows FATE's Receivables at $704000.0 in Q1 2026, $916000.0 in Q4 2025, and $682000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - | 704,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 704,000.00 |
| Dec 31, 2025 | 916,000.00 |
| Sep 30, 2025 | 682,000.00 |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 858,000.00 |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 2.83 Mn |
| Mar 31, 2023 | 13.50 Mn |
| Dec 31, 2022 | 38.48 Mn |
| Sep 30, 2022 | 10.22 Mn |
| Jun 30, 2022 | 13.13 Mn |
| Mar 31, 2022 | 13.85 Mn |
| Dec 31, 2021 | 8.68 Mn |
| Sep 30, 2021 | 7.31 Mn |
| Jun 30, 2021 | 10.30 Mn |